Contineum Therapeutics, Inc. (CTNM) Operating cash flow 2023–2025
Contineum Therapeutics, Inc. (CTNM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$55.3MFY2025 · since FY2023: $19.3M → -$55.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$55.3M | -68.4% |
| FY2024 | -$32.8M | -269.8% |
| FY2023 | $19.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice